Oxular
John Zemba has worked in the medical device industry since 2003. John began their career as a Technical Consultant - Regional Monitor for Independent Pharmaceuticals Professional. In 2020, they joined Genentech as a Surgical Device Liaison, where they were responsible for all aspects of Investigator and clinical staff training, certification and product device technical support. In 2021, they moved to Gyroscope Therapeutics as a Surgical Technical Expert. Currently, they are a Director, Device Training at Oxular.
John Zemba holds a Bachelor of Science in Mathematics and Computer Science from Eastern Michigan University.
This person is not in any offices
Oxular
Oxular is developing disruptive treatments for retinal diseases. Oxular’s sustained-release formulations are engineered to last up to one year following single administration and perform in specific small spaces in the eye.